Executive Vice President and Chief Development Officer

Jérôme Tiollier joined Innate in September 2001. Dr. Tiollier is a graduate of the University of Lyon and holds a doctorate in cellular biology and immunology.

Jérôme Tiollier previously worked at IMEDEX SA, a division of the Institut Mérieux (1986-1997), before joining the business unit IMTIX Transplant of Pasteur Mérieux (acquired by SANGSTAT in 1998) as Director of preclinical development (1997-1999) and Director of Research and Development Europe (1999-2001). In this latter position, he managed pharmaceutical projects (including Thymoglobulin and Antilfa) and was involved in the Group's medication research activities.